Brave Teddy Races Against Time for Cancer Trial

Brave Teddy is currently at Addenbrookes Hospital in Cambridge, battling severe headaches and vomiting as he awaits the start of a crucial treatment by September 12. The medication, DFMO, approved in the US as Iwilfin, is not routinely funded on NHS pathways in the UK.

His family faces significant costs for his treatment in America, including travel, insurance, tests, and accommodation for two years. Teddy's cancer was only detected during a routine eye exam last year; an optician noticed inflamed nerves, leading to further investigations.

This discovery was critical, as doctors indicated Teddy might have had only 12 weeks to live if his condition had not been identified. He has already undergone surgery, chemotherapy, and radiotherapy for metastatic medulloblastoma, a hostile childhood brain cancer.

With no further treatment options currently available in the UK, Teddy's family is urgently fundraising to get him to the US for the trial. The drug has shown a 95% success rate in similar cases, offering a vital hope for his recovery.